Enjoying the preview? The full article is just a click away.
Subscribe now or log in to keep reading.
Supportive Fundamentals
Announcement of ROCS X AI-enabled molecular search tool which could revolutionize drug discovery.
Partnership with TSMC enhancing AI-driven innovations in chip design and IP for advanced nodes.
Acquisition of Hexagon's Design & Engineering business, strengthening the simulation and analysis portfolio.
Analyst price targets raised significantly, with the latest target set at $400, indicating strong confidence in growth.
Points of Caution
Recent downgrades from several analysts indicating caution in short-term performance.
A slight drop in stock price noted amid broader market fluctuations, reflecting volatility.
High valuation with a P/E ratio around 94, raising concerns about sustainability of growth.
Dependence on partnerships such as with TSMC, which may face industry-wide challenges.
Impacting Factors
Product innovation and strong demand in AI/ML, making CDNS a key player in growing markets.
Positive sentiment from recent earnings report showing revenue growth, despite market dip.
Key acquisitions potentially driving long-term growth, positioning CDNS favorably against competitors.
Technical Trend
Technical Rating : Neutral
Stop Loss : 5%
Profit Potential : 10%
Target Price : 385
Strategy Spotlight - (HA Scalping)
All USD
All %
Long USD
Long %
Short USD
